These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12703323)

  • 41. Recent developments in the research of opioid receptor subtype molecular characterization.
    Wollemann M
    J Neurochem; 1990 Apr; 54(4):1095-101. PubMed ID: 2156011
    [No Abstract]   [Full Text] [Related]  

  • 42. [Advances in opioid receptor research].
    Fukuda K
    Masui; 2009 Nov; 58 Suppl():S211-7. PubMed ID: 22685742
    [No Abstract]   [Full Text] [Related]  

  • 43. Editorial: The Role of Opioid Receptors in Immune System Function.
    Rogers TJ; Roy S
    Front Immunol; 2021; 12():832292. PubMed ID: 35082800
    [No Abstract]   [Full Text] [Related]  

  • 44. Receptor targets in William Tell country: insights into receptor biology using fluorescent proteins.
    Mills A
    Trends Pharmacol Sci; 1998 Aug; 19(8):305-7. PubMed ID: 9745356
    [No Abstract]   [Full Text] [Related]  

  • 45. Lymphocyte modulation by seven transmembrane receptors: a brief review of session 1.
    Sharp BM
    Adv Exp Med Biol; 2001; 493():255-8. PubMed ID: 11727774
    [No Abstract]   [Full Text] [Related]  

  • 46. Opioid receptor expression and function.
    Sharp BM
    J Neuroimmunol; 2004 Feb; 147(1-2):3-5. PubMed ID: 14741416
    [No Abstract]   [Full Text] [Related]  

  • 47. [Development of a new cuvette for bio- and chemoluminescence measurements].
    Popov I; Lewin G
    Z Med Lab Diagn; 1984; 25(8):440-3. PubMed ID: 6523999
    [No Abstract]   [Full Text] [Related]  

  • 48. Fluorescent Proteins and Applications. Symposium proceedings. Palo Alto, California, USA, 6-7 March 1995.
    Gene; 1996; 173(1 Spec No):1-117. PubMed ID: 8707047
    [No Abstract]   [Full Text] [Related]  

  • 49. Opioid administration and rescue dose: exploring the effects of opioid combinations.
    Kraychete DC; Schmidt AP; Souza AKN; de Barros GAM
    Braz J Anesthesiol; 2023; 73(6):707-710. PubMed ID: 37574112
    [No Abstract]   [Full Text] [Related]  

  • 50. Compartment-specific opioid receptor signaling is selectively modulated by different dynorphin peptides.
    Kunselman JM; Gupta A; Gomes I; Devi LA; Puthenveedu MA
    Elife; 2021 Apr; 10():. PubMed ID: 33908346
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis and Pharmacology of a Novel μ-δ Opioid Receptor Heteromer-Selective Agonist Based on the Carfentanyl Template.
    Faouzi A; Uprety R; Gomes I; Massaly N; Keresztes AI; Le Rouzic V; Gupta A; Zhang T; Yoon HJ; Ansonoff M; Allaoa A; Pan YX; Pintar J; Morón JA; Streicher JM; Devi LA; Majumdar S
    J Med Chem; 2020 Nov; 63(22):13618-13637. PubMed ID: 33170687
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biased signaling by endogenous opioid peptides.
    Gomes I; Sierra S; Lueptow L; Gupta A; Gouty S; Margolis EB; Cox BM; Devi LA
    Proc Natl Acad Sci U S A; 2020 May; 117(21):11820-11828. PubMed ID: 32393639
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Targeting Cannabinoid 1 and Delta Opioid Receptor Heteromers Alleviates Chemotherapy-Induced Neuropathic Pain.
    Sierra S; Gupta A; Gomes I; Fowkes M; Ram A; Bobeck EN; Devi LA
    ACS Pharmacol Transl Sci; 2019 Aug; 2(4):219-229. PubMed ID: 31565698
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Opioid-Induced Signaling and Antinociception Are Modulated by the Recently Deorphanized Receptor, GPR171.
    McDermott MV; Afrose L; Gomes I; Devi LA; Bobeck EN
    J Pharmacol Exp Ther; 2019 Oct; 371(1):56-62. PubMed ID: 31308196
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Generation of G protein-coupled receptor antibodies differentially sensitive to conformational states.
    Heimann AS; Gupta A; Gomes I; Rayees R; Schlessinger A; Ferro ES; Unterwald EM; Devi LA
    PLoS One; 2017; 12(11):e0187306. PubMed ID: 29091950
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The BigLEN-GPR171 Peptide Receptor System Within the Basolateral Amygdala Regulates Anxiety-Like Behavior and Contextual Fear Conditioning.
    Bobeck EN; Gomes I; Pena D; Cummings KA; Clem RL; Mezei M; Devi LA
    Neuropsychopharmacology; 2017 Dec; 42(13):2527-2536. PubMed ID: 28425495
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of a small-molecule ligand that activates the neuropeptide receptor GPR171 and increases food intake.
    Wardman JH; Gomes I; Bobeck EN; Stockert JA; Kapoor A; Bisignano P; Gupta A; Mezei M; Kumar S; Filizola M; Devi LA
    Sci Signal; 2016 May; 9(430):ra55. PubMed ID: 27245612
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Collybolide is a novel biased agonist of κ-opioid receptors with potent antipruritic activity.
    Gupta A; Gomes I; Bobeck EN; Fakira AK; Massaro NP; Sharma I; Cavé A; Hamm HE; Parello J; Devi LA
    Proc Natl Acad Sci U S A; 2016 May; 113(21):6041-6. PubMed ID: 27162327
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular characterization of eluxadoline as a potential ligand targeting mu-delta opioid receptor heteromers.
    Fujita W; Gomes I; Dove LS; Prohaska D; McIntyre G; Devi LA
    Biochem Pharmacol; 2014 Dec; 92(3):448-56. PubMed ID: 25261794
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Salvinorin A regulates dopamine transporter function via a kappa opioid receptor and ERK1/2-dependent mechanism.
    Kivell B; Uzelac Z; Sundaramurthy S; Rajamanickam J; Ewald A; Chefer V; Jaligam V; Bolan E; Simonson B; Annamalai B; Mannangatti P; Prisinzano TE; Gomes I; Devi LA; Jayanthi LD; Sitte HH; Ramamoorthy S; Shippenberg TS
    Neuropharmacology; 2014 Nov; 86():228-40. PubMed ID: 25107591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.